Literature DB >> 23453935

Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care.

Marie Louise Tørring1, Morten Frydenberg2, Rikke P Hansen3, Frede Olesen3, Peter Vedsted3.   

Abstract

BACKGROUND: Early diagnosis is considered a key factor in improving the outcomes in cancer therapy; it remains unclear, however, whether long pre-diagnostic patient pathways influence clinical outcomes negatively. The aim of this study was to assess the association between the length of the diagnostic interval and the five-year mortality for the five most common cancers in Denmark while addressing known biases.
METHODS: A total of 1128 patients with colorectal, lung, melanoma skin, breast or prostate cancer were included in a prospective, population-based study in a Danish county. The diagnostic interval was defined as the time from the first presentation of symptoms in primary care till the date of diagnosis. Each type of cancer was analysed separately and combined, and all analyses were stratified according to the general practitioner's (GP's) interpretation of the presenting symptoms. We used conditional logistic regression to estimate five-year mortality odds ratios as a function of the diagnostic interval using restricted cubic splines and adjusting for comorbidity, age, sex and type of cancer.
RESULTS: We found increasing mortality with longer diagnostic intervals among the approximately 40% of the patients who presented in primary care with symptoms suggestive of cancer or any other serious illness. In the same group, very short diagnostic intervals were also associated with increased mortality. Patients presenting with vague symptoms not directly related to cancer or any other serious illness had longer diagnostic intervals and the same survival probability as those who presented with cancer suspicious/serious symptoms. For the former, we found no statistically significant association between the length of the diagnostic interval and mortality.
CONCLUSION: In full coherence with clinical logic, the healthcare system instigates prompt investigation of seriously ill patients. This likely explains the counter-intuitive findings of high mortality with short diagnostic intervals; but it does not explain the increasing mortality with longer diagnostic intervals. Thus, the study provides further evidence for the hypothesis that the length of the diagnostic interval affects mortality negatively.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23453935     DOI: 10.1016/j.ejca.2013.01.025

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  84 in total

1.  The relationship of cancer characteristics and patient outcome with time to lung cancer diagnosis after an abnormal screening CT.

Authors:  Sushilkumar K Sonavane; Paul Pinsky; Jubal Watts; David S Gierada; Reginald Munden; Satinder P Singh; Hrudaya Nath
Journal:  Eur Radiol       Date:  2017-06-14       Impact factor: 5.315

2.  Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada.

Authors:  Colleen Webber; Marlo Whitehead; Andrea Eisen; Claire M B Holloway; Patti A Groome
Journal:  Breast Cancer Res Treat       Date:  2021-01-24       Impact factor: 4.872

3.  Quality deviations in cancer diagnosis: prevalence and time to diagnosis in general practice.

Authors:  Henry Jensen; Aase Nissen; Peter Vedsted
Journal:  Br J Gen Pract       Date:  2014-02       Impact factor: 5.386

4.  Family physician access to and wait times for cancer diagnostic investigations: Regional differences among 3 provinces.

Authors:  Andriana Barisic; Maxine Kish; Julie Gilbert; Nicole Mittmann; Rahim Moineddin; Jeffrey Sisler; Peter Vedsted; Eva Grunfeld
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

5.  Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer.

Authors:  Clare Pearson; Jess Fraser; Michael Peake; Roland Valori; Veronique Poirier; Victoria H Coupland; Sara Hiom; Sean McPhail; Jodie Moffat; Georgios Lyratzopoulos; Jon Shelton
Journal:  Cancer Epidemiol       Date:  2019-06-15       Impact factor: 2.984

6.  Multilevel Approaches to Reducing Diagnostic and Treatment Delay in Colorectal Cancer.

Authors:  Sherri Sheinfeld Gorin
Journal:  Ann Fam Med       Date:  2019-09       Impact factor: 5.166

7.  Barriers and Explanatory Mechanisms of Delays in the Patient and Diagnosis Intervals of Care for Breast Cancer in Mexico.

Authors:  Karla Unger-Saldaña; Daniel Ventosa-Santaulària; Alfonso Miranda; Guillermo Verduzco-Bustos
Journal:  Oncologist       Date:  2017-12-28

8.  Identification of patients with non-metastatic colorectal cancer in primary care: a case-control study.

Authors:  Marcela Ewing; Peter Naredi; Chenyang Zhang; Jörgen Månsson
Journal:  Br J Gen Pract       Date:  2016-11-07       Impact factor: 5.386

9.  Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for Cancer: A Cluster Randomized Controlled Trial.

Authors:  Daniel R Murphy; Louis Wu; Eric J Thomas; Samuel N Forjuoh; Ashley N D Meyer; Hardeep Singh
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

10.  Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.

Authors:  Ruzica Z Conic; Claudia I Cabrera; Alok A Khorana; Brian R Gastman
Journal:  J Am Acad Dermatol       Date:  2017-10-17       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.